Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Clifford

Showing results (271-280 of 337) with videos related to

Pageof 34
Sort By:
Oncogene|December 23, 2014
Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenanceJ C Lindsey, D Kawauchi, E C Schwalbe, et al.
Cancers|January 11, 2022
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and TreatmentRebecca M Hill, Sabine L A Plasschaert, Beate Timmermann, et al.
Epigenetics|August 4, 2015
Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemiaAlem S Gabriel, Fadhel M Lafta, Edward C Schwalbe, et al.
Communications Biology|October 17, 2020
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cellsManon Penco-Campillo, Yannick Comoglio, Álvaro Javier Feliz Morel, et al.
Ebiomedicine|July 11, 2022
Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastomaMaïlys Rossi, Julie Talbot, Patricia Piris, et al.
Communications Biology|December 8, 2020
Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cellsManon Penco-Campillo, Yannick Comoglio, Álvaro Javier Feliz Morel, et al.
Acta Neuropathologica|January 8, 2013
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsiesEdward C Schwalbe, Daniel Williamson, Janet C Lindsey, et al.
Nature Communications|March 3, 2023
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumorsOliver J Mainwaring, Holger Weishaupt, Miao Zhao, et al.
Cell Reports|August 4, 2022
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar developmentDaniel Williamson, Edward C Schwalbe, Debbie Hicks, et al.
Plos One|September 5, 2008
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological featuresMarcel Kool, Jan Koster, Jens Bunt, et al.
Pageof 34

Showing results (271-280 of 337) with videos related to

Sort By:
Pageof 34
Oncogene|December 23, 2014
Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenanceJ C Lindsey, D Kawauchi, E C Schwalbe, et al.
Cancers|January 11, 2022
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and TreatmentRebecca M Hill, Sabine L A Plasschaert, Beate Timmermann, et al.
Epigenetics|August 4, 2015
Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemiaAlem S Gabriel, Fadhel M Lafta, Edward C Schwalbe, et al.
Communications Biology|October 17, 2020
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cellsManon Penco-Campillo, Yannick Comoglio, Álvaro Javier Feliz Morel, et al.
Ebiomedicine|July 11, 2022
Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastomaMaïlys Rossi, Julie Talbot, Patricia Piris, et al.
Communications Biology|December 8, 2020
Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cellsManon Penco-Campillo, Yannick Comoglio, Álvaro Javier Feliz Morel, et al.
Acta Neuropathologica|January 8, 2013
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsiesEdward C Schwalbe, Daniel Williamson, Janet C Lindsey, et al.
Nature Communications|March 3, 2023
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumorsOliver J Mainwaring, Holger Weishaupt, Miao Zhao, et al.
Cell Reports|August 4, 2022
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar developmentDaniel Williamson, Edward C Schwalbe, Debbie Hicks, et al.
Plos One|September 5, 2008
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological featuresMarcel Kool, Jan Koster, Jens Bunt, et al.
Pageof 34